JACOB LEONARD S 4
4 · ANTARES PHARMA, INC. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-18$2.24/sh+15,321$34,319→ 268,363 total - Sale
Common Stock
2021-02-18$5.05/sh−15,321$77,371→ 253,042 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-18−15,321→ 0 totalExercise: $2.24Exp: 2021-09-08→ Common Stock (15,321 underlying)
Footnotes (2)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested and become exercisable one year from the grant date of September 9, 2011.